PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hypertension and Diabetes, Medical University of Gdansk, Gdansk, Poland. info@professordworakowska.co.uk.\', \'Guys Richard Dimbleby Department of Cancer Research, Kings College London, London, UK.\', \'London International Clinic, London, UK.\', \'Centre for Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, UK.\', \'Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.26402/jpp.2020.2.01
?:doi
?:hasPublicationType
?:journal
  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
is ?:pmid of
?:pmid
?:pmid
  • 32633235
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all